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HIV-1 cDNA Integration: Requirement of HMG I(Y)
Protein for Function of Preintegration
Complexes In Vitro
Chris M. Farnet and Frederic D. Bushman so as to become joined to protruding 59 ends. The points
of joiningon each strand of the target DNA are separatedSalk Institute for Biological Studies
10010 North Torrey Pines Road by five base pairs. The enzymes responsible for at-
taching the other viral cDNA strand to target DNA haveLa Jolla, California 92024
not been identified but are likely contributed by host
DNA repair systems. Gap repair at the host–virus DNA
junctions completes the formation of an integrated pro-Summary
virus; the final gap repair step yields 5 bp duplications
of the target DNA at the integration junctions.We present data indicating thata host protein is impor-
The HIV-1 cDNA can be found in vivo in large nucleo-tant for function of HIV-1 preintegration complexes
protein complexes termed “preintegration complexes”(PICs) in vitro.PICs partially purified frominfected cells
(PICs). PICs can be isolated from freshly infected cells,were subjected to gel filtration in 600 mM KCl, which
and such complexes can carry out integration in vitroremoved a factor required for integration without fully
when presented with a model target DNA (Brown et al.,disrupting PICs. Addition of an extract from uninfected
1987; Ellison et al., 1990; Farnet and Haseltine, 1990;cells restored activity. Fractionation of the comple-
Lee and Coffin, 1990). Such reactions yield integrationmenting activity yielded HMG I(Y), a nonhistone chro-
intermediates in which each viral 39 end is attached tomosomal protein important for transcriptional control
a 59 end in target DNA; the subsequent gap repair stepand chromosomal architecture. Complementing activ-
does not occur efficiently. Artificial repair of gaps gener-ity could be isolated from PICs, and activity could be
ated by integration of HIV-1 PICs in vitro yields the ex-depleted from such fractions with an antibody against
pected 5 bp duplication of target DNA (Ellison et al.,HMG I(Y). Recombinant HMG I(Y) also complemented
1990; M. Hansen and F. D. B., unpublished data; K.salt-stripped complexes. The finding that a host pro-
Myrick and C. M. F., unpublished data).tein is required for integration by HIV PICs parallels
PICs are composed in part of a viral-encoded en-findings in several well-studied transposition and site-
zyme—integrase—that carries out DNA-cutting andspecific recombination systems.
-joining reactions central to integration (Farnet and Ha-
seltine, 1991). Purified integrase protein is capable of
Introduction removing two nucleotides from 39 ends of model LTR
DNAs (Katzman et al., 1989; Roth et al., 1989; Sherman
Viruses encode few of the functions necessary for their and Fyfe, 1990; Bushman and Craigie, 1991) and joining
own replication, relying primarily on host activities for the resulting recessed 39 hydroxyl to target DNA in vitro
growth. In the case of HIV-1, several host factors have (Bushman et al., 1990; Craigie et al., 1990; Katz et al.,
been identified, and the characterization of each has 1990). Purified HIV-1 integrase alone usually carries out
clarified central reactions in viral replication. For exam- a partial reaction in vitro in which only one LTR substrate
ple, the discovery that CD4 was the HIV receptor (Mad- becomes covalently attached to target DNA (Bushman
don et al., 1986) suggested models for the origin of and Craigie, 1991). Both integration in vivo and integra-
AIDS immunodeficiency, and the recent discovery that tion by PICs in vitro involve the coordinated joining of
chemokine receptors serve as cofactors for fusion (Alk- two viral DNA ends (Figure 1A). Reactions with PICs also
hatib et al., 1996; Deng et al., 1996; Doranz et al., 1996; differ from reactions with purified integrase in several
Feng et al., 1996) clarified puzzling findings on viral tro- further respects, such as in the response to small mole-
pism and resistance to infection in rare individuals (Dean cule inhibitors (Farnet et al., 1996).
et al., 1996; Liu et al., 1996). Host proteins carry out In addition to integrase and the HIV-1 cDNA, PICs
most of the reactions necessary for expression of viral have been reported to contain the viral matrix (MA),
genes and synthesis of viral proteins, and define several nucleocapsid (NC), reverse transcriptase (RT), and VPR
signal transduction pathways regulating HIV growth proteins (Bukrinsky et al., 1993; Gallay et al., 1995). Al-
(Varmus and Brown, 1989). Here we report the finding though these proteins are important for the synthesis
of a host protein apparently required for the integration of viral cDNA (RT and NC) or subcellular sorting of HIV
of viral cDNA into host DNA, a step in HIV-1 replication PICs (MA and VPR), none of the proteins are known to
not previously known to require host activities. be important for integration itself. The cDNA in PICs
The DNA breaking and joining reactions mediating exists in a folded state, with the viral ends held near
integration of HIV-1 cDNA are well understood (Figure one another and proteins bound at the ends (M. Miller
1A) (Varmus and Brown, 1989; Farnet and Bushman, and F. D. B., submitted). Whether further proteins are
1996). A linear form of the viral cDNA serves as the present in PICs is unknown.
immediate precursor of the integrated provirus. Prior to In the course of developing methods to purify HIV-1
integration, two nucleotides are removed from the39 end PICs, we obtained evidence that a factor important for
of each long terminal repeat (LTR), exposing recessed 39 integration in vitro was removed upon gel filtration of
hydroxyl groups. The recessed 39 hydroxyl groups then PICs in the presence of high salt concentrations. Activity
could be restored by addition of protein extracts fromattack phosphodiester bonds oneach target DNA strand
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uninfected human SupT1 cells. Here we report the isola-
tion and characterization of the complementing activity.
Results
Integration Complementing Activity in Extracts
of Uninfected Cells
In the course of purifying PICs from cells infected with
HIV-1, we observed that fractions containing PICs pre-
pared by differential precipitation with ammonium sul-
fate often lost activity. However, remixing fractions pre-
cipitated at different concentrations of salt restored
some activity. Since host factors have been found to be
important in several well-characterized recombination
systems (Berg and Howe, 1989; Lee and Craigie, 1994;
Nash, 1996), we investigated the question of whether
the complementing activity removed by high salt was
derived from the host cell.
HIV-1 PICs were partially purified and then stripped
by incubation in high concentrations of salt. First, PICs
were precipitated in low ionic strength buffer (75 mM
KCl), a step shown previously to remove at least 95%
of the total protein without loss of PICs or integration
activity (Farnet et al., 1996). The resulting pellets con-
taining PICs were resuspended in buffer with 600 mM
KCl and spun through CL4B gel filtration columns, which
have an excluded molecular weight of 2 3 107 kDa (such
complexes are referred to hereafter as “salt-stripped
PICs”). The ionic strength was then lowered to 150 mM
KCl. Salt-stripped PICs were not active for integration
after addition of a target DNA (Figure 1B, lane 1). How-
ever, PICs subjected to gel filtration in 150 mM KCl
retained activity (data not shown).
Addition of a crude extract from uninfected SupT1
cells to PICs in 600 mM KCl restored activity when the
salt was lowered to 150 mM KCl and target DNA added
(Figure 1B, lane 2). Integration activity returned to the
previous level, in which more than half of the viral cDNA
present in PICs became integrated into target DNA. Re-
action products made with reconstituted PICs were
characterized by cleavage with restriction enzymes (un-
published data). These data were fully consistent with
the view that such reactions yielded the expected inte-
gration intermediate (marked “II” in Figure 1A and on
the autoradiagrams). These data indicated that extracts
of uninfected cells could provide an activity that re-
placed that activity lost by salt-stripping of PICs. This
assay was then used to monitor fractionation steps dur-
ing purification of the complementing activity.
Figure 1. Integration Complementing Activity of a Host Cell Factor
and Evidence for DNA Binding were analyzedby Southern blotting; “cDNA” indicates the unreacted
viral DNA, “II” indicates the integration intermediate illustrated in(A) Inferred pathway of HIV cDNA integration in vivo. The HIV cDNA
is shown by the thin lines, the target DNA by the thick lines. Balls Figure 1A. This intermediate is known to be produced in reactions
with PICs.indicate DNA 59 ends. “II” denotes integration intermediate; “IP”
denotes integration product. The five base pairs of host DNA dupli- (C) Elution of complementing activity from ssDNA cellulose. Lane
1: salt-stripped PICs reconstituted with SupT1 extract. Lane 2: unre-cated owing to integration are shown as “rungs” in the ladder.
(B) The complementing activity binds DNA. Salt-stripped PICs were constituted PICs. Lane 3: PICs reconstituted with the ssDNA cellu-
lose flow-through fraction. Lanes 4–7: salt-stripped PICs reconstitu-incubated with buffer alone (lane 1), untreated SupT1 extract (lane
2), or extracts depleted with the indicated materials (lanes 3–5) ted with fractions eluted at the indicated concentrations of salt.
Reactions were carried out and analyzed as in Figure 1B.before lowering the salt and adding target DNA. Reaction products
HMG I(Y): A Cofactor for HIV cDNA Integration
485
Purification of the Complementing Activity
Yielded HMG I(Y) Protein
Since some of our initial observations could be ex-
plained if the complementing activity bound to DNA,
DNA cellulose was tested as a fractionation material.
Double-stranded (ds) DNA cellulose, single-stranded
(ss) DNA cellulose, or cellulose alone was added to com-
plementing extracts from uninfected SupT1 cells. After
incubation, thecellulose was removed by centrifugation.
Complementation by the remaining supernatants was
assayed byaddition tosalt-stripped PICs.No integration
activity was present in salt-stripped PICs reconstituted
with fractions depleted by dsDNA cellulose (Figure 1B,
lane 5) or ssDNA cellulose (Figure 1B, lane 4). Fractions
depleted with cellulose alone were able to restore activ-
ity (Figure 1B, lane 3).
Proteins bound to ssDNA cellulose were then eluted
at different salt concentrationsand fractions were tested
for complementing activity (Figure 1C). A fraction eluting
at 450 mM KCl was capable of restoring integration
activity (Figure 1C, lane 6). These data supported the
idea that the complementing activity could bind DNA.
The high mobility group (HMG) proteins, a class of
small DNA-binding proteins extractable from chromatin
with 0.35 M NaCl or 5% perchloric acid, have been
reported to be able to substitute in vitro for required
host factors in prokaryotic recombination systems (Paull
et al., 1994; Segall et al., 1994), and thus represented
candidates for the integration complementing activity.
Human HMG proteins were isolated by extracting SupT1
cells with 5% perchloric acid (Sanders and Johns, 1974)
and tested for the ability to complement salt-stripped
PICs. The HMG fraction did possess some complement-
ing activity, though it could not restore the level of inte-
gration to that seen with SupT1 extract (Figure 2A, lane
10). The HMG fraction also contained histone H1, which
was found to inhibit integration, accounting at least in
part for the inefficient complementation (data not shown).
The HMG fraction was then applied to a Mono S ion
exchange column and eluted with a KCl concentration
gradient. Fractions were analyzed for complementing
activity (Figure 2A) and for protein content by PAGE,
followed by staining with Coomassie brilliant blue (Fig-
ure 2B). Fraction 20 displayed clear complementing ac-
tivity (Figure 2A, lane 6) and contained a single promi-
nent band (Figure 2B, lane 10).
The size and fractionation profile of the species in Figure 2. Purification of Complementing Activity Yields HMG I(Y)
fraction 20 were consistent with those expected for (A) Analysis of the activity of acid extracted proteins and fraction-
HMG I(Y) protein. HMG I and HMG Y proteins are en- ation by Mono S chromatography. Total HMG proteins from SupT1
cells were loaded onto a Mono S column and eluted with a gradientcoded by the same gene; the two differ by an internal
of KCl (lanes 1–9). The initial load is in lane 10. Fractions were testeddeletion of 11 amino acids due to alternative RNA splic-
for the ability to restore activity to salt-stripped PICs and analyzeding (Disney et al., 1989). The two proteins cofractionate
by Southern blotting as described in the Experimental Procedures.
under many conditions and are referred to together as (B) Analysis of Mono S fractions by SDS-PAGE. The lane marked
HMG I(Y). The observed and calculated molecular (HT) HMG I contains a hexa-histidine tagged HMG I protein purified
weights differ, since the very high charge density of after overexpression in bacteria. The series of bands corresponds
HMG I(Y) causes it to migrate unusually slowly in the to truncations of the carboxylterminus that take place in bacteria.
(C) Western blot analysis of Mono S fractions. Fractions as in (B)SDS-PAGE system used here.
were blotted to a nitrocellulose membrane and probed with anTo confirm that fraction 20 containedHMG I(Y) protein,
a-HMG I antibody.Mono S fractions were blotted to a membrane and probed
(D) Western blot analysis of fractions eluted after binding to ssDNA
with an anti-HMG I(Y) antibody. A peak of reactive mate- cellulose as described in Figure 1C. Blots were probed with an
rial was seen in fraction 20 at the molecular weight a-HMG I antibody.
expected of HMG I(Y) (Figure 2C, lane 9). Less reactive
material was seen in flanking fractions. No reactive ma-
terial was seen in other fractions from the gradient.
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The fractions obtained earlier by elution from ssDNA
cellulose (Figure 1C) were then assayed for their HMG
I(Y) content by Western blotting (Figure 2D). A blot
probed with an anti-HMG I(Y) antibody revealed a band
of the size expected for HMG I(Y) in the fraction eluted
with 450 mM KCl (Figure 2D, lane 5), i.e., the fraction that
displayed complementing activity (Figure 1C, lane 6).
Thus, two methods for fractionating the complement-
ing activity fromSupT1 cells—digitonin permeabilization
followed by DNAcellulose fractionation and 5% perchlo-
ric acid extraction followed by Mono S chromatogra-
phy—each yielded HMG I(Y). Abundant HMG I(Y) was
not found in any fractions that failed to display comple-
menting activity.
HMG I(Y) Is Present in HIV-1 PICs
The above data indicate that HMG I(Y) is capable of
supplying complementing activity but do not address
the question of whether HMG I(Y) supplies this activity
in PICs as originally isolated. An extreme alternative
would be that salt-stripping of HIV-1 PICs removes some
required factor other than HMG I(Y). According to this
idea, addition of HMG I(Y) might restore activity but not
restore the original composition of PICs.
To address this possibility, PICs were first analyzed
to determine whether HMG I(Y) was present. PICs were
spun through gel filtration columns and the presence of
HMG I(Y) was assessed on Western blots probed with
an anti-HMG I(Y) antibody. A fraction containing PICs
subjected to gel filtration in the presence of 150 mM
KCl displayed a reactive protein at the molecular weight
expected for HMG I(Y) (Figure 3A, lane 2). A fraction
containing PICs subjected to gel filtration in the pres-
ence of 600 mM KCl, in contrast, did not contain detect-
able HMG I(Y) (Figure 3A, lane 3). An extract from unin-
fected SupT1 cells prepared in a similar fashion and
subjected to gel filtration in 150 mM KCl did not contain
HMG I(Y) (Figure 3A, lane 4). Recovery of PICs after gel
filtration was confirmed by Southern blot analysis of
DNA purified from the fractions analyzed (data not
shown). These data indicate that HMG I(Y) is associated
with HIV-1 PICs and removed by gel filtration in 600
mM KCl.
Parallel studies of viral proteins (data not shown) re-
vealed that integrase protein, MA, and RT were present
in fractions after gel filtration in 150 mM KCl and re-
mained associated after gel filtration in 600 mM KCl.
NC and CA proteins, in contrast, were undetectable in
fractions after gel filtration in 150 mM KCl, indicating
that large amounts of these proteins were not tightly
associated.
Antibodies against HMG I(Y) Deplete
Figure 3. HMG I(Y) Is Present in Partially Purified PICs, and Integra-
Complementing Activity Eluted from PICs tion Complementing Activity from PICs Can Be Depleted with an
To test whether HMG I(Y) protein in PICs is important a-HMG I(Y) Antibody
for function, complexes were treated with 600 mM KCl (A) Western blot detection of HMG I(Y) in PIC fractions after gel
filtration. Lane 1: HMG I(Y) protein standard. Lane 2: PICs resus-
pended in 150 mM KCl were purified by gel filtration in CL-4B spin
ultrafiltration, respectively; lanes 3–6 contain integrase and HMG columns equilibrated in150 mM KCl. Lane 3: PICs wereresuspended
in buffer containing 600 mM KCl and purified by gel filtration in 600I(Y) protein standards.
(C) Southern blot analysis of reactions containing complementing mM KCl. Lane 4: extract from uninfected SupT1 cells was subjected
to gel filtration in 150 mM KCl.activity depleted with different antibodies. The antibodies used for
depletion are marked above the gel over lanes 3–6. Lane 7 was (B) Western blot analysis of protein composition in filtrate and reten-
tate fractions after Centricon-100 ultrafiltration. Lanes 1 and 2 con-reconstituted with filtrate depleted with the a-HMG I(Y) antibody,
then SupT1 extract was added. tain 15 ml of the filtrate and retentate fractions from Centricon-100
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and the complementing activity released was then re- were formed (Figure 4, lanes 3–8). About 20%–50% of
reconstituted complexes carried out integration reac-covered and analyzed. PICs were partially purified by
precipitation in reduced ionic strength buffer, then re- tions, approaching, though not equaling, the original
level of 60%–80% integration. Very high concentrationssuspended in buffer containing 600 mM KCl. Samples
were then fractionated by ultrafiltration in Centricon-100 appeared to be slightly inhibitory (Figure 4, lane 3). Puri-
fied recombinant HMG Y was also able to reconstituteunits. Components of molecular weight less than 100
pass through such filters, while components of higher integration activity to the same level as HMG I (data not
shown).molecular weight, such as PICs, are retained. PICs in 4
ml were reduced in volume to 40 ml by ultrafiltration. Many other candidate proteins were tested for com-
plementing activity. All of the HMG proteins present inPICs were retained by the ultrafiltration membrane.
Complexes were washed once in high salt buffer and, SupT1 cells were tested, as shown in Figure 2. In addi-
tion, purified human HMG-1 and HMG-2 were also testedwhen tested, activity was found to be completely abol-
ished (Figure 3C, lane 1). Reconstitution with SupT1 separately at several concentrations and found to be
unable to supply complementing activity (Figure 4, lanesextract (Figure 3C, lane 2) or the filtrate fraction (Figure
3C, lane 3) restored integration activity. 15–20; unfortunately, for historical reasons unrelated
HMG proteins are named HMG-1 and HMG I). SeveralThe protein compositions of the retained PICs and
filtrate fractions were then investigated by Western blot- additional DNA-binding and DNA-bending proteins from
diverse sources were also tested (Table 1). In all cases,ting. HIV integrase protein partitioned about equally in
the filtrate and retentate fractions (compare Figure 3B, assays were carried out at a minimum of 3 concentra-
tions across at least a 100-fold concentration range.lanes 1 and 2, a-integrase). It is not clear whether the
free integrase was derived from the active PICs studied Some reconstituting activity was detected with high
levels of HIV-1 NC protein (Figure 4, lanes 9–11). Twentyor contaminating subviral material. A band of the size
expected for HMG I(Y), in contrast, was detected in the micrograms of NC protein per reaction could promote
integration of about 10% of the viral cDNA. Two and afiltrate fraction (Figure 3B, lane 1, a-HMG I[Y]). Only
trace amounts of HMG I(Y) were seen in the retained half micrograms of HMG I(Y), in contrast, could promote
integration of about 50% of the cDNA. The antibodysalt-stripped PICs (Figure 3B, lane 2). Evidently, HMG
I(Y) was removed from the PIC fraction by ultrafiltration depletion experiments in Figure 4 indicate that HMG
in 600 mM KCl, while much of the integrase protein I(Y) provides the predominant complementing activity
remained with PICs. present in PICs, and compositional studies indicate that
Several antibodies were then assayed for the ability NC is not present in PICs as isolated, arguing against
to deplete the filtrate-complementing activity released a major role for NC. Detergent-lysed HIV-1 virions, which
from PICs. Antibodies against HMG I(Y), HIV-1 MA, or contain abundant NC, were unable to supply comple-
HIV-1 NC were added to filtrate fractions, and bound menting activity (Figure 4, lanes 12–14). HIV-1 MA and
proteins recovered by binding to protein A sepharose integrase proteins were also unable to supply comple-
beads. Antibody-depleted filtrate fractions were then menting activity at the concentrations tested (Figure 4,
used to reconstitute salt-stripped PICs and integration lanes 24–26, and data not shown).
assayed. Antisera against HMG I(Y) removed the com-
plementing activity (Figure 3C, lane 4). Depletion of the
Discussionfiltrate with antibodies against HIV-1 MA or HIV-1 NC
failed to remove the complementing activity (Figure 3C,
Here we present data indicating that the high mobilitylanes 5 and 6). The a-HMG I(Y) antibody preparation
group protein HMG I(Y) is required for function of HIV-1was not nonspecifically inhibitory to integration, since
preintegration complexes (PICs) isolated from HIV-1-complexes treated with the a-HMG I(Y) antibody-
infected cells. We found initially that integration activitydepleted filtrate could be restored to activity by subse-
was lost from PICs following treatment with 600 mMquent addition of SupT1 extract (Figure 3C, lane 7).
KCl. Integration activity could be restored, however, byThe data in Figure 3 support the view that HMG I(Y)
addition of extracts from uninfected SupT1 cells, indi-is present in PICs as initially isolated and required for
cating that a host activity might be required. Purificationfunction in this setting.
of the complementing activity yielded HMG I(Y) protein.
HMG I and HMG Y proteins overexpressed in E. coli and
purified from that source were also sufficient to restore
integration activity tosalt-stripped PICs.Analysis of pro-Complementation with Purified Proteins
To strengthen the evidence that HMG I(Y) was the com- tein composition by Western blotting revealed that HMG
I(Y) was present in PICs, but depleted from PICs byplementing activity, HMG I protein was overexpressed
inE. coli, purified, and tested for complementing activity. high salt treatment. Complementing activity could be
obtained from preparations of PICs, and the activity inHMG I was purified either as a fusion protein containing
a hexahistidine tag (Thanos and Maniatis, 1992), or as such fractions specifically was removed by treatment
with an a-HMG I(Y) antibody. Purified HMG I(Y) alonethe authentic polypeptide purified by acid extraction
and MonoS chromatography. Purified HMG Iwas added was not sufficient to carry out integration when mixed
with purified HIV-1 cDNA (data not shown). These datato salt-stripped HIV-1 PICs, and the formation of integra-
tion products monitored. In the presence of HMG I puri- support a model in which HMG I(Y) is required as an
accessory factor for the function of HIV-1 PICs.fied by either means, abundant integration products
Cell
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Figure 4. Complementation with Purified Pro-
teins
Salt-stripped PICs were reconstituted with
the indicated proteins and activity analyzed
by Southern blotting. Amounts of proteins
added: lane 3–5: 25, 5, and 1 mg HMG I; lane
6–8: 2.5, 0.8, and 0.3 mg (HT) HMG I; lane
9–11: 20, 4, and 0.8 mg HIV-1 NC; lane 12: 10
ml virion extract; lanes 13 and 14, 1:5 and 1:25
dilutions of virion extract; lanes 15–17: 12.5,
1.25, and 0.125 mg of HMG-1; lanes 18–20: 12.5, 1.25, and 0.125 mg of HMG-2; lanes 21–23: 25, 2.5, and 0.25 mg of IHF; lanes 24–26: 20, 2,
or 0.2 mg of HIV-1 IN protein. Reaction volumes were 100–110 ml.
Possible Roles of HMG I(Y) in HIV-1 complement (unpublished data). Since target DNA is
present in great excess over HIV cDNA, it seems likelycDNA Integration
Our data allow us to identify at least one step in the that target DNA also serves as a competitor in this set-
ting, trapping HMG I(Y) and blocking binding to PICs. Ifintegration pathway that specifically requires HMG I(Y).
The covalent chemistry of integration involves two HMG I(Y) acted by binding to target DNA, no such inhibi-
tion would be expected.steps: cleavage of the viral cDNA ends to expose re-
cessed 39 hydroxyls and covalent joining of the viral Given the available data, it seems simplest to propose
that HMG I(Y) acts by binding to the HIV cDNA. HMGcDNA ends to phosphodiesters in the target DNA. We
find that the majority of the viral cDNA ends are cleaved I(Y) binds DNA as a monomer (Reeves and Nissen, 1990;
Maher and Nathans, 1996) at A/T rich sequences, partic-in PICs as initially isolated (M. Miller and F. D. B., submit-
ted). The finding that salt-stripped PICs with precleaved ularly sites containing at least five sequential A or T
residues, though binding is usually not highly sequenceends are inactive indicates that HMG I(Y) is important
at least for the covalent strand transfer step. specific (Strauss and Varshavsky, 1984; Elton et al.,
1987; Reeves et al., 1987). Potential binding sites forAs yet, the mechanism by which HMG I(Y) promotes
integration is unclear, though several models can be HMG I(Y) are present in the sequences of the HIV LTRs
(bases 11–15, 22–27, 249–253, 426–431, 439–443, 607–adduced. One model posits that HMG I(Y) acts by bind-
ing to integrase, perhaps acting as an allosteric effector. 611, and 622–626; numbers refer to the left LTR of
pNL4–3). Perhaps binding of HMG I(Y) alters the confor-However, attempts to demonstrate binding between
HMG I(Y) and purified HIV-1 integrase in vitro so far mation of the HIV cDNA so as to promote formation or
function of the catalytically active complex.have been unsuccessful (unpublished data), failing to
strengthen this hypothesis. HMG I(Y) might bind other One simple role for HMG I(Y) might be to bring the
two ends of the viral cDNA together in the active com-proteins in the PIC; no data are yet available that bear
on this possibility. It seems unlikely that HMG I(Y) acts plex. The ends must be brought into proximity normally,
since the points of joining of the two ends in target DNAby binding to the target DNA, since addition of HMG
I(Y) to salt-stripped PICs after addition of target fails to are always spaced by 5 bp (Vincent et al., 1990; Vink et
Table 1. Summary of Complementing Activity Present in Different Protein Fractions
Protein or Compound Complementing Activity? Source
HMG I(Y) 1 SupT1 cells
HMG I 1 E. coli expression
(HT)HMG I 1 E. coli expression
HIV-1 NC 1/2 E. coli expression
Serum albumin 2 Bovine
Total Histones 2 Calf thymus
Histone H1 2 Calf thymus
poly-lysine 2
protamine sulfate 2 Salmon sperm
T4 gene 32 protein 2 E. coli expression
RNase A 2 Bovine pancreas
RNase T1 2 Aspergillus oryzae
IHF 2 E. coli expression
HU 2 E. coli
SSB 2 E. coli expression
Uracil DNA glycosylase 2 Human
glyceraldehyde 3-phosphate dehydrogenase 2 Human
RPA 2 Human
LEF DNA-binding domain 2 E. coli expression
HMG-1 2 Human
HMG-2 2 Human
HIV-1 IN 2 E. coli expression
HIV-1 MA 2 E. coli expression
HIV-1 virion extract 2 Molt IIIB producer cells
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al., 1990; Stevens and Griffith, 1996). A protein bridge with the host proteins on substrate DNA. HMG I(Y) re-
sembles IHF, Hu, and Fis in that it is a small host DNA-is implicated in linking the cDNA ends, since cleavage
of the viral cDNA internally with a restriction enzyme binding protein that, when bound, alters the conforma-
tion of DNA (Thanos and Maniatis, 1992; Reeves anddoes not disrupt correct coupled joining (M. Miller and
F. D. B., submitted). However, one prediction of the idea Nissen, 1993; Lehming et al., 1994; Falvo et al., 1995;
Nissen and Reeves, 1995; Thanos and Maniatis, 1995;that HMG I(Y) bridges the cDNA ends is not met. We find
that salt-stripped PICs do not display uncoordinated Reeves and Wolffe, 1996), possibly mediating its role in
HIV integration.joining of single cDNA ends to target DNA. Such reac-
tions would yield Y-shaped DNA molecules, and these Purified HIV-1 integrase protein is active in vitro in the
absence of HMG I(Y) under certain conditions, againare not detected either as new product DNA species on
gels or as a depletion of the unreacted cDNA. If removal potentially paralleling results of studies of prokaryotic
recombination systems. Conditions in vitro have beenof HMG I(Y) does disrupt the association of the two
cDNA ends, this must be accompanied by reversible identified in which lambda-phage integrase, MuA trans-
posase, and Gin and Hin invertases each display cata-inactivation of integrase.
lytic activity in the absence of the host-encoded cofactor
(Johnson et al., 1986; Kanaar et al., 1986; Craigie and
Other Proposals for Auxiliary DNA-Binding Mizuuchi, 1987; Nash, 1990; Savilahti et al., 1995). These
Proteins Involved in Retroviral Integration reactions without host factors generally fail to mimic
A host protein has also been proposed to influence MLV recombination in vivo faithfully, displaying reduced effi-
integration, in this case preventing MLV PICs from using ciency, nonbiological reaction requirements, or yielding
their own cDNA as an integration target (Lee and Craigie, nonbiological reactions products. Similarly, for the case
1994). The active host protein fraction has not been of HIV, reactions in vitro with purified integrase mainly
fully characterized, and it is unknown whether the factor produce partial reaction products that mimic events at
one end of the viral cDNA only. Evidently, the full contextstudied is present in normal MLV PICs. It may be of
of the PIC is required to produce authentic productsinterest to compare the function of this possible host
efficiently, and this setting confers a requirement forcomponent with that of HMG I(Y).
HMG I(Y).In several previous studies, reactions in vitro con-
taining purified integrase protein have been reported to
HMG I(Y) as a Possible Sensorbe stimulated or inhibited by addition of other DNA-
for Regulatory Inputsbinding proteins (Fujiwara and Craigie, 1989; Bushman
In some of the prokaryotic recombination complexes,and Craigie, 1990; Bushman et al., 1990; Katz et al.,1990;
the requirement for host cofactors may have evolved toKalpana et al., 1994; Aiyar et al., 1996). The biological
link recombination activity with regulatory inputs, andsignificance of these effects is unclear, since many dif-
the same may hold for HMG I(Y) in HIV. Fis protein, forferent proteins, including prokaryotic proteins, have
example, varies in abundance at least 70-fold, de-been shown to provide the generally modest effects
pending on the growth state of E. coli cells (Thompsonobserved. We find that HMG I(Y) can also stimulate func-
et al., 1987). HMG I(Y) varies in abundance, dependingtion of purified integrase slightly (unpublished data), but
on growth state, and furthermore has been reportedwhether this stimulation reflects normal function in vivo
to be posttranslationally modified by phosphorylation,is unclear. It will be interesting to see if the proteins
adenylation, acetylation, methylation, and glycosylationreported to influence activity of purified integrase can
(Elton and Reeves, 1986). Phosphorylation of HMG I(Y)be found in PICs and shown to be important for function
has been reported to reduce the DNA-binding affinityin this context.
(Nissen et al., 1991; Reeves et al., 1991). Possible influ-
ences of these posttranslational modifications on inte-
gration can now be investigated using the PIC system.Roles of Host DNA-Binding Proteins in
The subcellular distribution of HMG I(Y) may also beTransposition and Site-Specific Recombination
significant for HIV replication. HMG I(Y) is not detectableThe finding that a host DNA-binding protein is important
in virions (unpublished data), so PICs must acquire HMGfor function of HIV PICs parallels previous findings in
I(Y) after infection of target cells. HMG I(Y) has beenseveral site-specific recombination and transposition
reported previously to be concentrated in the nucleussystems. Normal integrative recombination by lambda-
(Disney et al., 1989), so it is possible that in vivo integra-phage integrase, for example, requires the participation
tion is restricted to this compartment. This may be ad-of the E. coli protein IHF, which binds to the viral DNA
vantageous, since, in the cytoplasm, PICs might try toand bends it into the active conformation (for review,
use the only available DNA, their own cDNA, as an inte-see Nash, 1996). Mu-phage transposition requires the
gration target. Lack of HMG I(Y) in the cytoplasm mayparticipation of E. coli Hu protein, which binds to the
render the integration machinery inactive, potentiallyleft end of Mu DNA and helps bring monomers of MuA
preventing HIV from carrying out suicidal autointe-transposase into the active alignment (see Lavoie et al.,
gration.1996, and references therein). E. coli Fis protein, another
DNA-bending protein, is important for formation of DNA-
Experimental Proceduresinversion complexes by Gin and Hin invertases (for re-
view, see Merker et al., 1993). In each case, the active PIC Preparation
recombination complex is composed of several mono- Infections were initiated by cocultivating human SupT1 cells (2 3
106 cells/ml, grown in RPMI1640 medium containing 10% fetal calfmers of the recombination enzyme precisely organized
Cell
490
serum) with phorbol 12-myristate 13-acetate-stimulated MoltIIIB once in buffer K (20 mM HEPES [pH 7.5], 150 mM KCl, 5 mM MgCl2,
1 mM DTT, 10 units/ml aprotinin) and permeabilized by incubatingcells at a ratio of approximately 50:1. Cell extracts were prepared
5 hr after initiation of the coculture, as previously described (Farnet for 10 min in 15 ml of buffer K containing 0.025% digitonin. Cell
debris was pelleted by centrifugation at 1000 3 g for 3 min. Theand Haseltine, 1990). Crude extracts, containing approximately 0.5
ng/ml viral cDNA and 2 mg/ml protein, were frozen in 2 ml aliquots supernatant was clarified by centrifugation at 8000 3 g for 3 min,
adjusted to 10% (w/v) glycerol and 0.5 mM AEBSF, and storedat 2708C.
at 2708C.
For the fractionation of uninfected SupT1 extracts, extract fromSalt-Stripping of PICs
5 3 108 cells was loaded onto an ssDNA cellulose column (1 ml bedPICs in 2 ml of crude SupT1 extract were pelleted following precipi-
volume, 3.6 mg DNA/gram cellulose, Sigma) equilibrated in buffertation in low ionic strength buffer (Farnet et al., 1996). Pelleted PICs
K containing 10% (w/v) glycerol. Proteins were eluted with a stepwere resuspended in 510 ml of buffer T containing 600 mM KCl
gradient consisting of 300 mM KCl, 450 mM KCl, and 600 mM KCl(buffer T600; buffer T is 20 mM Tris [pH 8.0], 5 mM MgCl2, 1 mM
in buffer K containing 10% (w/v) glycerol. One milliliter fractionsDTT, 10 units/ml aprotinin). To separate salt-stripped factors from
were collected at each salt concentration, dialyzed against bufferpreintegration complexes, the resuspended PICs were divided into
K containing 10% (w/v) glycerol and 0.5 mM AEBSF, and stored3 aliquots of 170 ml and centrifuged over 3 Sepharose CL-4B spin
at 2708C.columns (1.5 ml bed volume each) equilibrated in buffer T600. Eluate
For the cellulose depletion experiments, 15 mg of cellulose (Sig-fractions contained salt-stripped PICs corresponding to a concen-
macel type 50, Sigma), ssDNA cellulose (3.6 mg DNA/gram cellulose,tration of approximately 2 ng viral cDNA per ml.
Sigma), or dsDNA cellulose (3 mg DNA/gram cellulose, Sigma) wasFor the experiments described in Figure 3A, PICs from 2 ml of
added to 250 ml of uninfected SupT1 extract and incubated at 48Cextract were resuspended in 170 ml of buffer T containing 600 mM
for 30 min with constant mixing. Celluloses werepelleted by centrifu-KCl, and centrifuged over a CL-4B column equilibrated in the same
gation at 104 3 g for 1 min, and the supernatants collected andbuffer. Non-salt-extracted PICs were prepared by resuspending
stored at 48C until used.PICs in buffer T containing 150 mM KCl and centrifuging over a CL-
For the experiments in Figures 3 and 4, extracts from uninfected4B column equilibrated in the same buffer. Control uninfectedSupT1
SupT1 cells were prepared by a modification of the procedure ofextracts were treated at low ionic strength, and the pelleted material
Wobbe et al. (1985). SupT1 cells (5 3 108) were washed two timeswas resuspended in buffer T containing 150 mM KCl and centrifuged
in cold PBS and once in hypotonic buffer (20 mM HEPES [pH 7.5],over a CL-4B column in the same buffer. Ten microliter aliquots of
5 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 10 units/ml aprotinin, 0.5 mMthe CL-4B eluates were analyzed for viral cDNA and integration
AEBSF). All subsequent steps were performed at 48C. Cells wereactivity. Protein present in 150 ml aliquots was precipitated by ace-
resuspended in 3 ml hypotonic buffer and incubated for 10 min.tone and analyzed on 15% SDS-polyacrylamide gels, followed by
Fifteen microliters of 5% digitonin (w/v in DMSO) was added, andWestern blotting by standard methods (Harlow and Lane, 1988)
incubation continued for 20 min before adding 125 ml of 5 M NaCl.using an HMG I(Y) antiserum.
After a 10 min incubation, the cell lysate was centrifuged at 105 3
g for 30 min. The supernatant fraction was dialyzed against 20 mMPIC Assays
HEPES (pH 7.5), 50 mM NaCl, 1 mM DTT, 0.1 mM EDTA, 10%Twenty-five microliters of salt-stripped PICs prepared by CL-4B gel
(w/v) glycerol, 10 units/ml aprotinin, 0.5 mM AEBSF, clarified byfiltration were incubated with 10 ml of buffer or protein fractions at
centrifugation at 105 3 g for 30 min, and stored in aliquots at 2708C.room temperature for 10 min. Buffer T containing 30% glycerol was
then added at a volume sufficient to reduce the monovalent cation
concentration to 150 mM, and the samples were incubated at room Purification of HMG Proteins from SupT1 Cells
temperature for an additional 10 min. Three microliters of linearized HMG proteins were prepared from SupT1 cells by a modification of
UX174 RF DNA (at 0.3 mg/ml in 150 mM KCl, 10 mM Tris HCl [pH the perchloric acid extraction procedure of Sanders and Johns
8.0], 5 mM MgCl2, 1 mM DTT) was then added, and the reactions (1974). SupT1 cells (2 3 109) were washed two times in cold PBS.
were incubated at 378C for 1 hr. Reaction products were purified All subsequent steps were performed at 48C. The cell pellet was
and analyzed by Southern blotting, as previously described (Farnet resuspended in 20 ml 5% perchloric acid and homogenized with 20
and Haseltine, 1990). Integration efficiency was determined by Phos- strokes in a dounce homogenizer. The homogenate was incubated
phorImager analysis of Southern blots. on ice for 30 min before spinning at 2000 3 g for 15 min. The pellet
was reextracted with 10 ml of 5% perchloric acid, and the two
supernatants pooled. The supernatant fraction was filtered throughUltrafiltration of PICs in High Salt
a 0.45-micron filter and acidified by adding 0.03 vol of concentratedFor the experiment described in Figure 3B, PICs from 2 ml of extract
HCl. Proteins were precipitated by adding 6.2 vol of acetone andwere precipitated by incubation at low ionic strength and resus-
pelleted by centrifugation at 2000 3 g for 30 min in a swingingpended in 525 ml of buffer T600. Five hundred microliters of the
bucket rotor. The HMG protein pellet was washed twice with coldsample was centrifuged for 1 hr at 1000 3 g at room temperature
acetone, dried, resuspended in 3 ml of buffer A containing 10 mMin a Centricon-100 ultrafiltration unit (Amicon), generating a 40 ml
NaCl (buffer A is 10 mM Tris HCl [pH 7.5], 1 mM DTT, 10% (w/v)retentate fraction and a 450 ml filtrate fraction. Two microliters of
glycerol), and filtered through a 0.45-micron filter. Proteins wereretentate was incubated with 25 ml of buffer T600 or 25 ml of the
fractionated by FPLC using a Mono S column (HR 5/5, 1 ml bedfiltrate fraction before diluting with buffer T containing 30% (w/v)
volume, Pharmacia). The HMG proteins were loaded onto a columnglycerol to reduce the KCl concentration to 150 mM. After a 10 min
equilibrated in buffer A containing 10 mM KCl and eluted with aincubation, target DNA was added and the reaction incubated for
0.01–1 M gradient of KCl in buffer A at a flow rate of 1 ml/min.1 hr at 378C. For the experiment described in Figure 3C, PICs from
Twenty-seven fractions (0.5 ml) were collected, pooled in groups of6 ml of extract were resuspended in 510 ml of buffer T600 and
two, and dialyzed against 20 mM HEPES (pH 7.5), 50 mM NaCl,subjected to ultrafiltration in the same manner. The retentate (40 ml)
1 mM DTT, 0.1 mM EDTA, 10% (w/v) glycerol, 10 units/ml aprotinin,was diluted with 500 ml fresh buffer T600 and subjected to ultrafiltra-
0.5 mM AEBSF. Protein in the fractions was detected by electropho-tion a second time to remove residual salt-stripped factors. Filtrate
resis on 15% SDS-polyacrylamide gels followed by Coomassie bluefrom the first ultrafiltration was diluted with 3 volumes of buffer T
staining.to reduce the KCl concentration to 150 mM. For immunodepletion
of the filtrate, 5 ml of the indicated antiserum was incubated with
200 ml of filtrate for 2 hr at 48C. Immune complexes were precipitated Purification of HMG I(Y) from E. coli Cells
by adding 25 ml of protein A-sepharose CL-4B beads (Pharmacia) after Overexpression
for 1 hr and centrifuging briefly. HMG I(Y) was purified from E. coli cells by two methods. In one
case, a modified version of HMG I containing an amino-terminal
hexahistidine tag was purified on chelating sepharose charged withUninfected SupT1 Extracts
Uninfected SupT1 extracts were prepared using the same extraction nickel, essentially as described (Thanos and Maniatis, 1995). This
yielded a preparation containing three bands, each of which reactedbuffer used to isolate PICs from infected cells. Cells were washed
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with an a-HMG I(Y) antibody. Evidently, the two shorter peptides Craigie, R., and Mizuuchi, K. (1987). Joining of Mu to target DNA
can be uncoupled from cleavage at the end of Mu. Cell 51, 493–501.were truncated near the carboxyl-terminus. In the second method,
a plasmid (pET7CIY) directing expression of authentic HMG I(Y) Craigie, R., Fujiwara, T., and Bushman, F. (1990). The IN protein of
(Reeves and Nissen, 1993) was used. E. coli strain BL21/DE3 con- Moloney murine leukemia virus processes the viral DNA ends and
taining pET7CIY was grown to mid-log in Terrific Broth (Sambrook accomplishes their integration in vitro. Cell 62, 829–837.
et al., 1989) and induced by adding IPTG to a concentration of 1 mM.
Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W.,After 2.5 hr, cells were harvested, washed in 10 mM Tris (pH 8), and
Allikments, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gom-lysed by adding lysozyme to 1 mg/ml, followed by incubation for
perts, E., et al. (1996). Genetic restriction of HIV-1 infection and30 min on ice and sonication. The lysate was extracted by adding
progression to AIDS by a deletion ALLELE of the CKR5 structuralperchloric acid to 5% (vol/vol) and dounce homogenized with 20
gene. Science 273, 1856–1862.strokes. The lysate was centrifuged for 20 min at 3000 rpm in a
Deng, D., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart,Sorval RC 3B rotor, and the supernatant filtered through a 0.45-
M., DiMarzio, P., Marmon, S., Sutton, R.E., and Hill, C.M. (1996).micron filter. The filtrate was acidified by addition of 0.03 vol of
Identification of a major co-receptor for primary isolates of HIV-1.concentrated HCl, and precipitated by addition of 6.2 vol of acetone.
Nature 381, 661–666.After centrifugation as above, the pellet was washed twice with cold
acetone, dried, and resuspended in 3 ml of buffer A with 50 mM Disney, J.E., Johnson, K.R., Magnuson, N.S., Sylvester, S.R., and
NaCl. The resuspended acetone pellet was then applied to a Mono Reeves, R. (1989). High-mobility group protein HMG-I localizes to
S column (Pharmacia) and eluted with a 0.05–1 M gradient of NaCl G/Q- and C-bands of human and mouse chromosomes. J. Cell Biol.
in buffer A. Peak fractions contained a single prominent band. Analy- 109, 1975–1982.
sis of the protein in this fraction by mass spectrometry and amino- Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper,
terminal sequencing indicated that it had the molecular weight ex- S.C., Parmentier, M., Collman, R.G., and Dorns, R.W. (1996). A dual-
pected for HMG I(Y) after removal of the amino-terminal methionine. trophic primary HIV-1 isolate that uses Fusin and the b-chemokine
receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85,
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